6848 logo

RBC Bioscience Corporation Stock Price

TPEX:6848 Community·NT$286.9m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

6848 Share Price Performance

NT$20.10
2.74 (15.76%)
NT$20.10
2.74 (15.76%)
Price NT$20.10

6848 Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Slight risk with acceptable track record.

4 Risks
1 Reward

RBC Bioscience Corporation Key Details

NT$219.7m

Revenue

NT$118.2m

Cost of Revenue

NT$101.5m

Gross Profit

NT$77.9m

Other Expenses

NT$23.5m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
1.65
46.18%
10.72%
145.1%
View Full Analysis

About 6848

Founded
1995
Employees
50
CEO
Mingwei Zhuo
WebsiteView website
www.rbcbioscience.com

RBC Bioscience Corporation manufactures and sells reagents and devices for life science and molecular diagnosis. It offers robotic bench-top workstation for nucleic acid purification under the MagCore Plus II and Giga Automated Nucleic Acid Extractor names; MagCore Super Automated Nucleic Acid Extractor, an automated workstation for nucleic acid extraction; and MagCore EDA Automatic Extraction and Smart PCR Setup, an instrument for nucleic acid extraction and PCR setup pre-treatment. The company also provides NGS, genomic DNA, viral nucleic acids, and total RNA kits. It has operations in Taiwan, rest of Asia, Africa, the United States, and internationally. RBC Bioscience Corporation was founded in 1995 and is based in New Taipei City, Taiwan.

Recent 6848 News & Updates

Recent updates

No updates